4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress is organized by MarketsandMarkets (MnM) Conferences and will be held from Mar 10 - 11, 2020 at London, England, United Kingdom.
Who should attend:
VPs, heads, directors, managers, leaders, engineers, scientists, working in
• Cell Culture
• Cell Therapy
• Upstream Processing
• Stem Cell therapy
• Process Development
• Downstream Processing
• Quality Control
• Translational Sciences
Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.
In this conference we would be focusing on the pre-clinical, manufacturing, clinical and regulatory aspects of cell therapies and regenerative medicine. The special impact would be laid on tissue engineering, car-T cell-based immunotherapies, automated manufacturing, allogenic therapies, with the aspects of hurdles in supply chain management and regulatory affairs.
Additional details will be posted as soon as information is available.
|Contact No. :||+91 020 48598 285
|Registration Type||Last Date||Price|
|Academic Delegate - Standard Fee||09 Mar,2020||EUR 395.00|
|Solution Provider Delegate - Standard Fee||09 Mar,2020||EUR 1199.00|
|Registration Type||End Date||Price|
|Pharma/Biotech Delegate Fee||31 Oct,2019||EUR 695.00|
|Pharma/Biotech Delegate - Super Early Fee||30 Oct,2019||EUR 521.00|
|Pharma/Biotech Delegate - Early Fee||30 Nov,2019||EUR 556.00|
|Academic Delegate - Super Early Fee||30 Oct,2019||EUR 296.00|
|Academic Delegate - Early Fee||30 Nov,2019||EUR 316.00|
|Solution Provider Delegate - Super Early Fee||30 Oct,2019||EUR 900.00|
|Solution Provider Delegate - Early Fee||30 Nov,2019||EUR 959.00|